NeoProgen is Drug Discovery in United States that focus on developer business. Founded in 2019. They cover business area such as developer, cell-base therapy, people, patient, advanced heart failure, neonatal Cardiac Progenitor Cells, tissue, lifesave heart surgery, baby, congenital heart condition, medical practitioner, advance heart failure.
2019
( 5 years old in 2024 )
Developer
-
323 West Camden Street
Suite 600
Baltimore, MD 21201
United States
Private
developercell-base therapypeoplepatientadvanced heart failureneonatal Cardiac Progenitor Cellstissuelifesave heart surgerybabycongenital heart conditionmedical practitioneradvance heart failure
* We use standard office opening hours in near NeoProgen's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
NeoProgen is Drug Discovery business from United States that founded in 2019 (5 years old in 2024), NeoProgen business is focusing on Developer.
NeoProgen headquarter office and corporate office address is located in 323 West Camden Street Suite 600 Baltimore, MD 21201 United States.
NeoProgen was founded in United States.
In 2024, NeoProgen is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with NeoProgen, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
